Share:
Peer-Reviewed Publication
Lancet2026;407(10547):2499-2500.June 20, 2026Letter

Rapid tests for Bundibugyo virus in DR Congo.

Ranu S Dhillon1, Abraar Karan2, Devabhaktuni Srikrishna3, Jean-Vivien Mombouli4, Robert F Garry5
1Optimize Health, Raghogarh 473226, Madhya Pradesh, India. Electronic address: ranu.dhillon@optimize.org.
2Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA.
3Patient Knowhow, San Mateo, CA, USA.
4Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of the Congo.
5Department of Microbiology and Immunology, Tulane University Medical Center, New Orleans, LA, USA; Zalgen Labs, Germantown, MD, USA; Global Viral Network, Tampa, FL, USA.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.